Codexis Future Growth
Future criteria checks 1/6
Codexis is forecast to grow earnings and revenue by 45.5% and 19.9% per annum respectively while EPS is expected to grow by 47.7% per annum.
Key information
45.5%
Earnings growth rate
47.7%
EPS growth rate
| Life Sciences earnings growth | 19.4% |
| Revenue growth rate | 19.9% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 86 | -36 | -21 | N/A | 4 |
| 12/31/2025 | 67 | -53 | -35 | N/A | 7 |
| 12/31/2024 | 65 | -58 | -55 | N/A | 8 |
| 9/30/2024 | 64 | -62 | -46 | -44 | N/A |
| 6/30/2024 | 61 | -76 | -49 | -47 | N/A |
| 3/31/2024 | 74 | -65 | -54 | -51 | N/A |
| 12/31/2023 | 70 | -76 | -57 | -53 | N/A |
| 9/30/2023 | 74 | -82 | -41 | -37 | N/A |
| 6/30/2023 | 99 | -57 | -6 | -1 | N/A |
| 3/31/2023 | 116 | -48 | 8 | 13 | N/A |
| 12/31/2022 | 139 | -34 | 3 | 11 | N/A |
| 9/30/2022 | 133 | -31 | -7 | 7 | N/A |
| 6/30/2022 | 135 | -19 | -29 | -13 | N/A |
| 3/31/2022 | 122 | -21 | -35 | -19 | N/A |
| 12/31/2021 | 105 | -21 | -28 | -14 | N/A |
| 9/30/2021 | 101 | -15 | -26 | -16 | N/A |
| 6/30/2021 | 83 | -23 | -26 | -20 | N/A |
| 3/31/2021 | 72 | -25 | -27 | -21 | N/A |
| 12/31/2020 | 69 | -24 | -20 | -16 | N/A |
| 9/30/2020 | 67 | -21 | -21 | -19 | N/A |
| 6/30/2020 | 70 | -14 | -20 | -16 | N/A |
| 3/31/2020 | 68 | -14 | -15 | -11 | N/A |
| 12/31/2019 | 68 | -12 | -16 | -13 | N/A |
| 9/30/2019 | 66 | -12 | -14 | -10 | N/A |
| 6/30/2019 | 61 | -14 | -12 | -10 | N/A |
| 3/31/2019 | 62 | -11 | -16 | -13 | N/A |
| 12/31/2018 | 61 | -11 | -17 | -14 | N/A |
| 9/30/2018 | 66 | -9 | -8 | -6 | N/A |
| 6/30/2018 | 59 | -18 | N/A | -9 | N/A |
| 3/31/2018 | 56 | -20 | N/A | -9 | N/A |
| 12/31/2017 | 50 | -23 | N/A | -9 | N/A |
| 9/30/2017 | 38 | -29 | N/A | -12 | N/A |
| 6/30/2017 | 43 | -18 | N/A | -14 | N/A |
| 3/31/2017 | 49 | -9 | N/A | -6 | N/A |
| 12/31/2016 | 49 | -9 | N/A | -2 | N/A |
| 9/30/2016 | 50 | -5 | N/A | 0 | N/A |
| 6/30/2016 | 53 | -1 | N/A | 8 | N/A |
| 3/31/2016 | 43 | -9 | N/A | 4 | N/A |
| 12/31/2015 | 42 | -8 | N/A | 0 | N/A |
| 9/30/2015 | 44 | -5 | N/A | -3 | N/A |
| 6/30/2015 | 34 | -15 | N/A | -1 | N/A |
| 3/31/2015 | 35 | -18 | N/A | -1 | N/A |
| 12/31/2014 | 35 | -19 | N/A | 0 | N/A |
| 9/30/2014 | 31 | -29 | N/A | -9 | N/A |
| 6/30/2014 | 27 | -34 | N/A | -19 | N/A |
| 3/31/2014 | 28 | -38 | N/A | -22 | N/A |
| 12/31/2013 | 32 | -41 | N/A | -23 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0I0X is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0I0X is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0I0X is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0I0X's revenue (19.9% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0I0X's revenue (19.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0I0X's Return on Equity is forecast to be high in 3 years time